This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2000 Feb;4(1):2-5.

doi: 10.1034/j.1399-3046.2000.00093.x.

Therapeutic drug monitoring of cyclosporin A: should we use the area under the concentration-time curve and forget trough levels?

PMID: 10731051
DOI: 10.1034/j.1399-3046.2000.00093.x

Editorial

Therapeutic drug monitoring of cyclosporin A: should we use the area under the concentration-time curve and forget trough levels?

P F Hoyer. Pediatr Transplant. 2000 Feb.

. 2000 Feb;4(1):2-5.

doi: 10.1034/j.1399-3046.2000.00093.x.

Author

PMID: 10731051
DOI: 10.1034/j.1399-3046.2000.00093.x

No abstract available

PubMed Disclaimer

Comment on

Changing cyclosporin A formulation: an analysis in paediatric cardiac transplant recipients.
Gennery AR, O'Sullivan JJ, Hasan A, Hamilton JR, Dark JH. Gennery AR, et al. Pediatr Transplant. 1999 Aug;3(3):215-8. doi: 10.1034/j.1399-3046.1999.00033.x. Pediatr Transplant. 1999. PMID: 10487282
Limited sampling model for area-under-the-curve monitoring in pediatric patients receiving either Sandimmune or Neoral cyclosporin A oral formulations.
Medeiros M, Pérez-Urizar J, Muñoz R, Castañeda-Hernández G. Medeiros M, et al. Pediatr Transplant. 1999 Aug;3(3):225-30. doi: 10.1034/j.1399-3046.1999.00037.x. Pediatr Transplant. 1999. PMID: 10487284 Clinical Trial.
Sandimmune to Neoral conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipients.
Kelles A, Herman J, Tjandra-Maga TB, Van Damme-Lombaerts R. Kelles A, et al. Pediatr Transplant. 1999 Nov;3(4):282-7. doi: 10.1034/j.1399-3046.1999.00058.x. Pediatr Transplant. 1999. PMID: 10562972

Similar articles

Sandimmune to Neoral conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipients.
Kelles A, Herman J, Tjandra-Maga TB, Van Damme-Lombaerts R. Kelles A, et al. Pediatr Transplant. 1999 Nov;3(4):282-7. doi: 10.1034/j.1399-3046.1999.00058.x. Pediatr Transplant. 1999. PMID: 10562972
Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation.
Mahalati K, Belitsky P, Sketris I, West K, Panek R. Mahalati K, et al. Transplantation. 1999 Jul 15;68(1):55-62. doi: 10.1097/00007890-199907150-00011. Transplantation. 1999. PMID: 10428267
[What significance has the C(2) value in the treatment with cyclosporin A?].
Pham VV, Stichtenoth DO, Frölich JC. Pham VV, et al. Dtsch Med Wochenschr. 2004 Mar 26;129(13):706. doi: 10.1055/s-2004-821376. Dtsch Med Wochenschr. 2004. PMID: 15026970 German. No abstract available.
Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients.
Belitsky P, Dunn S, Johnston A, Levy G. Belitsky P, et al. Clin Pharmacokinet. 2000 Aug;39(2):117-25. doi: 10.2165/00003088-200039020-00003. Clin Pharmacokinet. 2000. PMID: 10976658 Review.
[Therapeutic follow-up of cyclosporine. Main factors involved in the interpretation of results].
Cheymol G. Cheymol G. Therapie. 1992 Jul-Aug;47(4):319-21. Therapie. 1992. PMID: 1494795 Review. French.

See all similar articles

Cited by

Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients.
Kassir N, Labbé L, Delaloye JR, Mouksassi MS, Lapeyraque AL, Alvarez F, Lallier M, Beaunoyer M, Théorêt Y, Litalien C. Kassir N, et al. Br J Clin Pharmacol. 2014 Jun;77(6):1051-63. doi: 10.1111/bcp.12276. Br J Clin Pharmacol. 2014. PMID: 24977292 Free PMC article.
Therapeutic drug monitoring in pediatric renal transplantation.
Weber LT. Weber LT. Pediatr Nephrol. 2015 Feb;30(2):253-65. doi: 10.1007/s00467-014-2813-8. Epub 2014 Apr 25. Pediatr Nephrol. 2015. PMID: 24763544 Review.
Advantages of cyclosporin A using 2-h levels in pediatric kidney transplantation.
Pape L, Ehrich JH, Offner G. Pape L, et al. Pediatr Nephrol. 2004 Sep;19(9):1035-8. doi: 10.1007/s00467-004-1481-5. Epub 2004 Jul 10. Pediatr Nephrol. 2004. PMID: 15248059
Absorption phase cyclosporine (C(2h)) monitoring in the first weeks after pediatric renal transplantation.
Vester U, Kranz B, Offner G, Nadalin S, Paul A, Broelsch CE, Hoyer PE. Vester U, et al. Pediatr Nephrol. 2004 Nov;19(11):1273-7. doi: 10.1007/s00467-004-1617-7. Pediatr Nephrol. 2004. PMID: 15365805

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley